Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00718
|
|||||
Drug Name |
Tubercidin
|
|||||
Synonyms |
Sparsamycin A
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Discovery agent [ICD11:N.A.] | Investigative | ||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C11H14N4O4
|
|||||
Canonical SMILES |
C1=CN(C2=NC=NC(=C21)N)C3C(C(C(O3)CO)O)O
|
|||||
InChI |
InChI=1S/C11H14N4O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2,(H2,12,13,14)/t6-,7-,8-,11-/m1/s1
|
|||||
InChIKey |
HDZZVAMISRMYHH-KCGFPETGSA-N
|
|||||
CAS Number |
CAS 69-33-0
|
|||||
Pharmaceutical Properties | Molecular Weight | 266.25 | Topological Polar Surface Area | 127 | ||
Heavy Atom Count | 19 | Rotatable Bond Count | 2 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | |||
XLogP |
-1.3
|
|||||
PubChem CID | ||||||
PubChem SID |
103171721
,103914905
,104311514
,117356057
,124812646
,128047323
,134971531
,134978868
,137248889
,143236531
,144187478
,14872494
,152146259
,152198607
,162202461
,162250667
,178101465
,179561976
,182462121
,198982412
,223702430
,226399501
,241383350
,24899902
,249864885
,252072294
,252212958
,252403405
,26757019
,29225241
,46392900
,46530721
,47193881
,50040490
,50506281
,57323288
,621129
,7890700
,7980854
,8153925
,92474076
,93166873
|
|||||
ChEBI ID |
CHEBI:48267
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | ENT3 | Transporter Info | Equilibrative nucleoside transporter 3 | Substrate | [1] | |
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | ENT3 | Transporter Info | Km =1860 microM | Xenopus Oocytes-ENT3 | [1] | |
References | ||||||
1 | Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem. 2005 Apr 22;280(16):15880-7. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.